| Date | Title | Description | Source |
| 22.02.2024 | Relay Therapeutics Reports Fourth Quarter and Full Year 2023... | Completed enrollment in initial RLY-2608 600mg + fulvestrant dose expansion cohort & initiated a... | einpresswi... |
| 08.01.2024 | Relay Therapeutics Announces $30 Million Private Placement F... | CAMBRIDGE, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clini... | einpresswi... |
| 08.01.2024 | Relay Therapeutics Announces $30 Million Private Placement F... | - | globenewsw... |
| 04.05.2023 | Relay Therapeutics Reports First Quarter 2023 Financial Resu... | /EIN News/ -- Presented initial clinical data for RLY-2608 at American Association for Cancer Resear... | einpresswi... |
| 13.04.2023 | Conga Announces Winners of 2023 Inspire Awards at Annual Con... | The quality of this year’s customer nominations is a true testament to the power and impact that Rev... | prweb.com/... |
| 10.12.2021 | Relay Therapeutics Announces Preclinical Data that Support C... | CAMBRIDGE, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clini... | marketscre... |
| 08.10.2021 | Relay Therapeutics : Announces Interim Clinical Data that Su... | Interim data suggest that RLY-4008 is a highly selective FGFR2 inhibitor that has not shown to be li... | marketscre... |
| 08.10.2021 | Relay Therapeutics : Announces Preclinical Data that Support... | Relay Therapeutics Announces Preclinical Data that Support RLY-2608 as the First Known Allosteric Pa... | marketscre... |
| 07.10.2021 | Relay Therapeutics : Announces Preclinical Data that Support... | RLY-2608 preferentially binds mutant PI3Kα at a novel allosteric site discovered by the Dynamo™ plat... | marketscre... |
| 16.04.2021 | RELAY THERAPEUTICS, INC.
Relay Therapeutics Extends Leaders... | Relay Therapeutics’ leadership in this new breed of biotech positions the company as a strategic par... | marketscre... |
| 25.02.2021 | Biotech and healthtech firm Foresite Capital raises $969M ne... | The firm, which now has over $4 billion in assets under management, invests across all stages
The bi... | vator.tv/n... |
| 16.07.2020 | Relay Therapeutics prices IPO at $400M | Relay initially filed to go public with the Securities and Exchange Commission on June 25, stating t... | medcitynew... |
| 10.07.2020 | Relay Therapeutics, focused on solid tumors, seeks to raise ... | Relay Therapeutics, a Cambridge, Mass.-biotech focusing on cancer treatments, plans to raise $250 mi... | statnews.c... |
| 25.06.2020 | Protein motion-focused Relay Therapeutics files for $200M IP... | While targeted drugs often work by preventing the binding of a ligand to its active site, Relay’s al... | medcitynew... |
| 27.12.2018 | Relay Therapeutics Lands $400M Series C |
CAMBRIDGE, MA, Relay Therapeutics announced the successful completion of a $400 million Series C f... | vcnewsdail... |
| 20.12.2018 | Relay Therapeutics hits VC jackpot with $400M Series C round... | The company’s Series B financing was completed on Dec. 14, 2017 and valued at $63 million. BVF Partn... | medcitynew... |
| 20.12.2018 | Biotech startup Relay Therapeutics raises $400 million from ... | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn m... | venturebea... |
| 20.12.2018 | Term Sheet — Thursday, December 20 | 5 Qs WITH A DEALMAKER
Earlier this month, French President Emmanuel Macron invited a contingent of 4... | fortune.co... |
| 20.12.2018 | Relay Therapeutics Secures $400 Million in Series C Financin... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Relay Therapeutics, a new breed of company at the intersection of... | archive.ci... |
| 20.12.2018 | Relay Therapeutics raises $400 million in venture capital fu... | Relay Therapeutics is expected to announce Thursday that it has raised $400 million in venture capit... | statnews.c... |
| 20.12.2018 | Relay Therapeutics Secures $400M in Series C Financing | Relay Therapeutics, a Cambridge, Mass.-based company working at the intersection of computation and ... | finsmes.co... |
| 20.12.2018 | Relay Therapeutics Secures $400 Million in Series C Financin... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Relay Therapeutics, a new breed of company at the intersection of... | citybizlis... |
| 20.12.2018 | Daily funding roundup - December 20th, 2018 | Layer1 raised $2.1M; Gamelearn raised $5M; BacklotCars raised $8; DrChrono raised $10M
Layer1: Layer... | vator.tv/n... |
| 20.12.2018 | Biotech startup Relay Therapeutics raises $400 million from ... | Relay Therapeutics, a biotechnology startup that’s meshing computational power with the latest exper... | venturebea... |
| 02.04.2018 | Boston Startups and Tech Companies Hiring in April | April is the month to haul the grill out of the basement and also to dust off that musty resume. Bos... | bizjournal... |
| 15.12.2017 | Term Sheet — Friday, December 15 | THE CRYSTAL BALL
Happy Friday, Term Sheet readers.
Paid Content You can't secure what you can't see ... | fortune.co... |
| 14.12.2017 | Relay Therapeutics Raises $63M Series B | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Relay Therapeutics, a biotech company dedicated to developing bre... | archive.ci... |
| 14.12.2017 | Relay Therapeutics Completes $63M Series B Financing | Relay Therapeutics, a Cambridge, Mass.-based biotech company dedicated to developing medicines by le... | finsmes.co... |
| 14.12.2017 | Relay Therapeutics Raises $63M Series B | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Relay Therapeutics, a biotech company dedicated to developing bre... | citybizlis... |
| 14.12.2017 | Relay Therapeutics Secures $63 Million in Series B Financing | Proceeds to Support Advancement of Pipeline of Oncology Candidate Therapies and Further Development ... | venturebea... |
| 14.12.2017 | Relay Therapeutics Nabs $63M |
CAMBRIDGE, MA, Relay Therapeutics, a biotech company dedicated to developing breakthrough medicine... | vcnewsdail... |
| 14.12.2016 | Third Rock invests $55M in ‘kidney renaissance’ startup | As a result of that close nurturing, Third Rock partner and interim Goldfinch CEO Abbie Celniker sai... | medcitynew... |
| 16.09.2016 | Protein-motion startup launches armed with $57M to develop d... | Molecular-level movies may not spark the imagination of too many directors. But for oncology patient... | medcitynew... |
| 15.09.2016 | Relay Therapeutics Raises $57M in Series A Financing | Relay Therapeutics, a Cambridge, Massachusetts-based newly formed drug discovery company, raised $57... | finsmes.co... |
| 14.09.2016 | Relay Therapeutics Launches with $57M Series A |
CAMBRIDGE, MA, Third Rock Ventures, LLC today announced the formation of Relay Therapeutics with $... | vcnewsdail... |
| 14.09.2016 | Third Rock Ventures Launches Relay Therapeutics with $57 Mil... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the formation of Relay T... | citybizlis... |
| - | Meet the 23 biotech startups that are set to take off in the... | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and s... | businessin... |
| - | Protein-motion startup launches armed with $57M to develop d... | A picture may be worth a thousand words, but when it comes to disease discovery, Bay Area VC firm Th... | medcitynew... |
| - | Protein motion-focused Relay Therapeutics files for $200M IP... | A company that less than two years ago raised $400 million in a venture capital funding round has fi... | medcitynew... |
| - | Third Rock invests $55M in ‘kidney renaissance’ startup | Third Rock Ventures has rallied a $55 million Series A to launch Goldfinch Bio, a startup that aims ... | medcitynew... |
| - | 9 top West Coast biotechs that VCs say are poised to take of... | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers... | businessin... |
| - | Relay Therapeutics hits VC jackpot with $400M Series C round... | A discovery-stage biopharma startup focused on protein motion in drug discovery has raised a round o... | medcitynew... |
| - | Relay Therapeutics prices IPO at $400M | A company focused on discovering drugs through research into protein motion has announced the pricin... | medcitynew... |
